Research investment accelerated
Marinova’s global leadership in fucoidan science has been further strengthened through significant investment in Australian research.
“Marinova continues to collaborate with a wide range of outstanding research partners across the globe,” said the company’s Research Director Dr Barbara Wimmer. “We are pleased to be expanding our research investment in 2026 by undertaking a suite of additional research projects here in Australia. These studies will leverage the world class scientific capabilities of leading Australian universities. We now have projects underway at The University of Tasmania, Adelaide University, Flinders University, The University of Queensland and Griffith University.”
In recent years Australia has moved to fast-track the growth of its marine bio-industries to meet rapidly growing global demand for efficacious and sustainable products. The country’s Marine Bioproducts Cooperative Research Centre (MB-CRC) is a $270M consortium of industry, government and academic partners driving collaborative research partnerships. “Marinova is pleased to be a core industry partner in the MB-CRC and working alongside Australia’s leading researchers to improve health outcomes,” said Dr Wimmer. “Marinova has also partnered with Australia’s Food and Beverage Accelerator (FaBA) to explore further innovations for the functional food and beverage category.”
The company’s range of Maritech® organic fucoidans are the world’s only high purity, certified organic fucoidans with global regulatory acceptance. Sustainably sourced and clinically validated, they are sought after by some of the world's most trusted healthcare brands. Maritech® organic fucoidans are included as premium ingredients in market-leading nutritional supplements, functional foods and beverages, skincare formulations, and animal health products.
“In addition to Marinova’s own extensive R&D program, the company is also the supplier of choice to world-renowned research institutions,” finished Dr Wimmer. “The unrivalled quality and efficacy of Marinova’s fucoidan extracts make them sought after for independent studies across the medical device and pharmaceutical sectors.”